RET NM_020975.6(RET):c.5_28dup (p.Ala9_Gly10insAlaLysAlaThrSerGlyAlaAla) — variant · CancerIndex

Variant · Insertion

RET NM_020975.6(RET):c.5_28dup (p.Ala9_Gly10insAlaLysAlaThrSerGlyAlaAla)

CI-VAR-00174827Explore in graph →p.Ala9_Gly10insAlaLysAlaThrSerGlyAlaAlaNM_020975.6:c.5_28dupClinVar 1020843 rs1837063549

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
1020843	Uncertain significance	criteria provided, multiple submitters, no conflicts	2	Multiple endocrine neoplasia, type 2; Hereditary cancer-predisposing syndrome	germline	3	Oct 09, 2025	clinvar